3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
8
Glioblastoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Brain Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Sarcoma
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscle-invasive Urothelial Cancer of the Bladder
1
Mouth Neoplasms
1
Lymphoma, Follicular
1
Laryngeal Neoplasms
1
Glioma
1
Giant Cell Tumor of Bone
1
Ganglioneuroblastoma
1
Estrogen Receptor Positive Breast Cancer
1
Craniopharyngioma
1
Carcinoma
1
Astrocytoma
1
Alzheimer Disease
1
Interventions
Gemcitabine
19
Mitomycin
10
Docetaxel
7
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Transurethral Resection of Bladder
×
1 year
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled